Active Ingredient History
Ranitidine, a histamine H2-receptor antagonist, is now well established as a potent inhibitor of gastric acid secretion effective in the treatment and prophylaxis of gastrointestinal lesions aggravated by gastric acid secretion. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Duodenal Ulcer (approved 1983)
Gastroesophageal Reflux (approved 1983)
Peptic Ulcer (approved 1983)
Zollinger-Ellison Syndrome (approved 1983)
Anesthesia (Phase 4)
Aspirin (Phase 4)
Bacterial Infections (Phase 4)
Blood Protein Disorders (Phase 2)
Breast Neoplasms (Phase 2/Phase 3)
Carcinoma, Renal Cell (Phase 2)
Coronary Artery Disease (Phase 4)
Cough (Phase 3)
Critical Illness (Phase 4)
Diabetes Mellitus, Type 2 (Phase 1)
Drug Interactions (Phase 4)
Dyspepsia (Phase 4)
Esophageal Neoplasms (Phase 3)
Eustachian Tube (Phase 4)
Food-Drug Interactions (Phase 1)
Gastritis (Phase 4)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1/Phase 2)
Heart Failure (Phase 1)
Helicobacter pylori (Phase 2/Phase 3)
Hematologic Diseases (Phase 2)
Hemodynamics (Phase 4)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 1)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Hypotension, Orthostatic (Phase 1)
Immune System Diseases (Phase 2)
Infections (Phase 2)
Intestinal Pseudo-Obstruction (Phase 4)
Job Syndrome (Phase 2)
Kidney Failure, Chronic (Phase 2)
Laryngopharyngeal Reflux (Phase 4)
Leukemia (Phase 1)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Mastocytosis, Systemic (Phase 1)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Nausea (Phase 4)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplastic Cells, Circulating (Phase 2)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 4)
Paraproteinemias (Phase 2)
Peptic Ulcer ()
Pharmacokinetics (Phase 1)
Plasmacytoma (Phase 1)
Pneumonia, Ventilator-Associated (Phase 4)
Postpartum Hemorrhage (Phase 2)
Prostatic Neoplasms (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Pure Autonomic Failure (Phase 1)
Stomach Ulcer (Phase 3)
Thyroid Neoplasms (Phase 1)
Ulcer (Phase 4)
Vomiting (Phase 4)
Voriconazole (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue